We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

162 hedge funds and large institutions have $1.22B invested in Acorda Therapeutics in 2018 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 53 increasing their positions, 43 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

93% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 15

23% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 43

11% more capital invested

Capital invested by funds: $1.09B → $1.22B (+$123M)

8% more funds holding

Funds holding: 150 → 162 (+12)

57% less call options, than puts

Call options by funds: $17.2M | Put options by funds: $39.5M

Holders
162
Holders Change
+12
Holders Change %
+8%
% of All Funds
3.71%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
29
Increased
53
Reduced
43
Closed
15
Calls
$17.2M
Puts
$39.5M
Net Calls
-$22.4M
Net Calls Change
-$14.1M

Top Buyers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
+$19.2M
2
Millennium Management
Millennium Management
New York
+$13.4M
3
FAM
Fred Alger Management
New York
+$9.29M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.37M
5
Renaissance Technologies
Renaissance Technologies
New York
+$5.18M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$26.6M
2
AQR Capital Management
AQR Capital Management
Connecticut
-$7.79M
3
Morgan Stanley
Morgan Stanley
New York
-$7.78M
4
BIM
Bogle Investment Management
Massachusetts
-$5.35M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$5.03M
Name Holding Trade Value Shares
Change 		Change in
Stake
GCP
51
GSA Capital Partners
United Kingdom
$1.98M +$2.09M +699 New
GC
52
Guggenheim Capital
Illinois
$1.97M -$225K -75 -10%
Swiss National Bank
53
Swiss National Bank
Switzerland
$1.95M – – –
CS
54
Credit Suisse
Switzerland
$1.95M -$180K -60 -8%
PI
55
PineBridge Investments
New York
$1.88M -$21K -7 -1%
AQR Capital Management
56
AQR Capital Management
Connecticut
$1.86M -$7.79M -2,601 -80%
California Public Employees Retirement System
57
California Public Employees Retirement System
California
$1.78M +$174K +58 +10%
ASRS
58
Arizona State Retirement System
Arizona
$1.75M -$117K -39 -6%
California State Teachers Retirement System (CalSTRS)
59
California State Teachers Retirement System (CalSTRS)
California
$1.56M -$59.9K -20 -4%
COPPSERS
60
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.5M +$1.58M +529 New
AA
61
ALPS Advisors
Colorado
$1.49M +$278K +93 +22%
Acadian Asset Management
62
Acadian Asset Management
Massachusetts
$1.48M +$937K +313 +150%
AllianceBernstein
63
AllianceBernstein
Tennessee
$1.47M -$973K -325 -39%
Los Angeles Capital Management
64
Los Angeles Capital Management
California
$1.45M +$491K +164 +47%
Canada Life
65
Canada Life
Manitoba, Canada
$1.42M – – –
CSS
66
Cubist Systematic Strategies
Connecticut
$1.42M +$1.49M +499 New
New York State Teachers Retirement System (NYSTRS)
67
New York State Teachers Retirement System (NYSTRS)
New York
$1.4M – – –
Bank of America
68
Bank of America
North Carolina
$1.32M -$225K -75 -14%
MCC
69
Malaga Cove Capital
California
$1.28M +$174K +58 +15%
GAM
70
Gotham Asset Management
New York
$1.21M +$177K +59 +16%
CIP
71
Convergence Investment Partners
Florida
$1.21M – – –
HSA
72
Hussman Strategic Advisors
Maryland
$1.18M +$1.25M +417 New
Massachusetts Financial Services
73
Massachusetts Financial Services
Massachusetts
$1.16M +$18K +6 +1%
Comerica Bank
74
Comerica Bank
Texas
$1.15M +$35.9K +12 +3%
OAM
75
Oxford Asset Management
United Kingdom
$1.13M -$1.7M -569 -59%
1 2
3
4 5

ACOR Hedge Fund Activity: Q1 2018 in Review

162 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q1 2018, worth a combined $1.22B — up 11% from $1.09B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new ACOR positions and 15 closed out — a net gain of 14 holders — while 53 added to existing stakes and 43 trimmed.

The largest buyer was HealthCor Management, opening a new position worth an estimated $19.2M. The largest seller was Invesco, cutting an estimated $26.6M.

  • 162 institutional investors held Acorda Therapeutics (ACOR) as of Q1 2018, up from 150 in Q4 2017.
  • Funds reported $1.22B of Acorda Therapeutics stock for Q1 2018, up 11% quarter-over-quarter.
  • 29 funds opened new Acorda Therapeutics positions in Q1 2018 and 15 closed out, a net change of +14 holders.
  • The largest Acorda Therapeutics buyer in Q1 2018 was HealthCor Management, an estimated $19.2M added.
  • The largest Acorda Therapeutics seller in Q1 2018 was Invesco, an estimated $26.6M sold.

Based on aggregated 13F filings for Q1 2018.